Teladoc Health (TDOC) Common Equity (2013 - 2026)

Teladoc Health's Common Equity history runs 14 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Common Equity fell 6.36% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 6.36% YoY), while the FY2025 annual figure was $1.4 billion, down 7.07% from the prior year.
• Common Equity came in at $1.3 billion for Q1 2026 at Teladoc Health, down from $1.4 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $9.1 billion in Q1 2022 to a low of $1.3 billion in Q1 2026.
• A 5-year average of $2.7 billion and a median of $2.3 billion in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity plunged 85.62% in 2022 and advanced 0.79% in 2023, its largest moves.
• Teladoc Health's Common Equity stood at $2.3 billion in 2022, then rose by 0.79% to $2.3 billion in 2023, then tumbled by 35.9% to $1.5 billion in 2024, then fell by 7.07% to $1.4 billion in 2025, then retreated by 3.56% to $1.3 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $1.3 billion, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison